awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35192198-6CCF08B5-0F26-4E97-A0A9-6CADC4732E2E
Q35192198-6CCF08B5-0F26-4E97-A0A9-6CADC4732E2E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35192198-6CCF08B5-0F26-4E97-A0A9-6CADC4732E2E
Efficacy and safety of canagliflozin alone or as add-on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52-week open-label study.
P2860
Q35192198-6CCF08B5-0F26-4E97-A0A9-6CADC4732E2E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35192198-6CCF08B5-0F26-4E97-A0A9-6CADC4732E2E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ebfe001c030da28891a6d3b85e0ea1448511cc2f
P2860
Inhibition of the sodium glucose co-transporter-2: its beneficial action and potential combination therapy for type 2 diabetes mellitus.